Clinical Trial Update: Building Evidence for Advancing New Treatment for Rifampicin Resistant Tuberculosis (RR-TB) Comparing a Short Course of Treatment (Containing Bedaquiline, Delamanid and Linezolid) With the Current South African Standard of Care [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating a short-course regimen containing bedaquiline, delamanid, and linezolid versus the current standard of care for rifampicin-resistant tu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensively Drug-resistant Tuberculosis
• Multidrug-resistant Tuberculosis
• Pre-extensively Drug-resistant Tuberculosis
• Rifampicin-resistant Tuberculosis
• Tuberculosis

Drugs mentioned

• Deltyba (delamanid)
• SIRTURO (bedaquiline fumarate)
• ZYVOX (LINEZOLID)

Snippet

Sponsor: Wits Health Consortium (Pty) Ltd | Conditions: Tuberculosis, Pre-XDR-TB | Phase 3 | Status: COMPLETED